Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU

Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU

Submitted by admin on December 7, 2021 - 11:04am
Source: 
Biopharma Reporter
News Tags: 
Roche
Actemra
RoActemra
COVID-19
Europe
Headline: 
Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU
snippet: 

The European Commission has extended the marketing authorisation for Actemra/RoActemra (tocilizumab) to include the treatment of severe COVID-19 in adults.

Do Not Allow Advertisers to Use My Personal information